INSP:NYSE, Inspire Medical Systems, Inc.
INSP stock overview
Inspire Medical Systems, Inc. (INSP:NYSE) closed at $61.10 on November 13, 2026,
up 0.93% on the day.
The stock trades 58.4% below its 52-week high of $147.03
and 57.0% above its 52-week low of $38.91.
Over the past year, it lost 29.2%.
Inspire Medical Systems, Inc. is part of the Health Care sector (Medical/Dental Instruments).
Key figures
- Price
- $61.10
- Day change
- +0.93%
- Volume
- 574,380
- Average volume
- 760,648
- Market cap
- 1B+
- 52-week range
- $38.91 – $147.03
- 50-day average
- $68.97
- 200-day average
- $57.53
Price action over the past year
In 252 trading sessions since November 13, 2025, INSP closed higher on 120 days (48%).
Its best day was November 24, 2025 (+30.51%) and its worst was December 18, 2025 (-19.45%).
The stock moved 10% or more in a single session 8 times.
It opened at least 5% above the previous day's high 2 times.
Recent signals
INSP news
-
Nov 11, 2026:
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
-
Nov 10, 2026:
INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here?
-
Nov 10, 2026:
Stocks making big moves this week: Sprout Social, Redwire, Inspire Medical Systems, Fastly, and Marvell Technology
-
Nov 5, 2026:
Has Inspire Medical Systems (INSP) Fallen Far Enough on Cash Flow?
-
Nov 5, 2026:
Inspire Medical Systems Stock Has The Bull Case Changed After Narrowed Guidance
-
Nov 4, 2026:
Inspire Medical Systems Inc (INSP) Q3 2026 Earnings Call Highlights: Revenue Slips 7. ...
-
Nov 4, 2026:
Inspire Medical Systems (INSP) Posts A Mixed Quarter, Is The Stock Trading At A Discount?
-
Nov 4, 2026:
Inspire Medical Systems (INSP) Stock Slides As Q3 Earnings Turn Lossmaking
About Inspire Medical Systems, Inc.
Inspire Medical Systems Inc operates as a medical technology company. The firm develops implantable neurostimulation systems to treat obstructive sleep apnea.
Similar stocks
Find more stocks like INSP with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.